Mirae Asset Global Investments
OLMA icon

Mirae Asset Global Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Mirae Asset Global Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.9K Sell
3,907
-274
-7% -$3.67K ﹤0.01% 1358
2026
Q1 		$62.3K Buy
4,181
+359
+9% +$7.99K ﹤0.01% 1253
2025
Q4 		$95.5K Buy
3,822
+1,169
+44% +$20.8K ﹤0.01% 1264
2025
Q3 		$26K Buy
2,653
+10
+0.4% +$60 ﹤0.01% 1457
2025
Q2 		$11.3K Buy
2,643
+159
+6% +$709 ﹤0.01% 1473
2025
Q1 		$10.2K Buy
2,484
+575
+30% +$2.89K ﹤0.01% 1471
2024
Q4 		$11.7K Sell
1,909
-162
-8% -$1.62K ﹤0.01% 1495
2024
Q3 		$25.2K Buy
2,071
+401
+24% +$5.13K ﹤0.01% 1400
2024
Q2 		$18.7K Sell
1,670
-8,869
-84% -$96.2K ﹤0.01% 1388
2024
Q1 		$119K Sell
10,539
-5,412
-34% -$69.8K ﹤0.01% 2348
2023
Q4 		$224K Buy
15,951
+1,367
+9% +$18.4K ﹤0.01% 2303
2023
Q3 		$180K Hold
14,584
– – ﹤0.01% 2332
2023
Q2 		$132K Buy
+14,584
New +$88.1K ﹤0.01% 2451

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments's OLMA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Olema Pharmaceuticals (OLMA) stake by 6.6% in Q2 2026, selling an estimated $3.67K and leaving 3,907 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Mirae Asset Global Investments first reported a position in OLMA in Q2 2023 and has held it in 13 quarters since. The position peaked at $224K in Q4 2023. 45 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Mirae Asset Global Investments held 3,907 shares of Olema Pharmaceuticals worth $48.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 274 Olema Pharmaceuticals shares in Q2 2026, an estimated $3.67K.
  • Olema Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1358 holding.
  • Mirae Asset Global Investments first reported a position in Olema Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Mirae Asset Global Investments's Olema Pharmaceuticals position peaked at $224K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.